Table 2 Expression of VIM (Z-score ≥ 1) according to the top mutations present in AML (N = 173 patients)
Genes | Z-score (< 1) (n = 145) | Z-score (≥ 1) (n = 28) | p value |
|---|---|---|---|
FLT3 (n, %) | 41 (28.3%) | 8 (28.6%) | > 0.999 |
TP53 (n, %) | 14 (9.66%) | 0 (0.00%) | 0.130 |
NPM1 (n, %) | 35 (24.1%) | 13 (46.4%) | 0.021 |
NRAS (n, %) | 10 (6.90%) | 2 (7.14%) | > 0.999 |
TET2 (n, %) | 14 (9.66%) | 1 (3.57%) | 0.470 |
RUNX1 (n, %) | 14 (9.66%) | 1 (3.57%) | 0.470 |
CEBPA (n, %) | 12 (8.28%) | 1 (3.57%) | 0.696 |
WT1 (n, %) | 10 (6.90%) | 0 (0.00%) | 0.369 |
DNMT3A (n, %) | 34 (23.4%) | 8 (28.6%) | 0.631 |
IDH1 (n, %) | 13 (8.97%) | 3 (10.7%) | 0.726 |
IDH2 (n, %) | 13 (8.97%) | 4 (14.3%) | 0.484 |